Effect of 1,25-dihydroxyvitamin D3 on human cancer cells in vitro
- 31 December 1987
- journal article
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 27 (4-6) , 825-828
- https://doi.org/10.1016/0022-4731(87)90155-5
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Antigen detection by the monoclonal antibodies CA 19-9 and CA 125 in normal and tumor tissue and patients' seraZeitschrift für Krebsforschung und Klinische Onkologie, 1986
- Individual chemosensitivity of in vitro proliferating mammary and ovarian carcinoma cells in comparison to clinical results of chemotherapyZeitschrift für Krebsforschung und Klinische Onkologie, 1985
- 1α,25-Dihyroxyvitamin D3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytesBiochemical and Biophysical Research Communications, 1983
- The Vitamin D Endocrine System: Steroid Metabolism, Hormone Receptors, and Biological Response (Calcium Binding Proteins)*Endocrine Reviews, 1982
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- 1,25-DIHYDROXYVITAMIN-D RECEPTOR IN BREAST CANCER CELLSThe Lancet, 1979
- Influence of Vitamin D3, 1,25-Dihydroxyvitamin D3, and 24,25-Dihydroxyvitamin D3on Parathyroid Hormone Secretion, Adenosine 3 ′,5′-Monophosphate Release, and Ultrastructure of Parathyroid Glands in Organ Culture*Endocrinology, 1979